BRIEF published on 07/07/2026 at 15:00, 2 hours 13 minutes ago Piramal Pharma Reports FY2026 Achievements in Annual Report Innovation Sustainability Revenue Annual Report Global Growth
BRIEF published on 07/07/2026 at 15:00, 2 hours 13 minutes ago Piramal Pharma présente ses réalisations pour l'exercice 2026 dans son rapport annuel Innovation Durabilité Rapport Annuel Croissance Mondiale Revenu
PRESS RELEASE published on 07/07/2026 at 14:55, 2 hours 18 minutes ago Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones Piramal Pharma Limited's FY2026 Annual Report highlights global growth, innovation, and sustainability achievements. Revenue from operations and business insights included Sustainability Annual Report Global Growth Piramal Pharma Limited FY2026
BRIEF published on 04/28/2026 at 22:00, 2 months 8 days ago Piramal Pharma Limited Reports FY26 Financial Results Strategic Investment Revenue Decline Segment Growth Piramal Pharma Limited Financial Results 2026
BRIEF published on 04/28/2026 at 22:00, 2 months 8 days ago Piramal Pharma Limited publie ses résultats financiers pour l'exercice 2026 Investissement Stratégique Baisse Des Revenus Croissance Du Segment Piramal Pharma Limited Résultats Financiers 2026
PRESS RELEASE published on 04/28/2026 at 21:55, 2 months 8 days ago Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 Piramal Pharma Limited announces Q4 and full-year FY26 results, highlighting growth in revenue, EBITDA margin, and key business developments amidst external disruptions. Read more here Financial Report Q4 Results Business Highlights FY26 Piramal Pharma Limited
BRIEF published on 01/29/2026 at 06:55, 5 months 9 days ago Piramal Pharma Reports Decline in Revenue and Profit for Q3 and 9M FY26 EBITDA Margin Revenue Decline Facility Expansion Biopharma Funding Kenalog Acquisition
BRIEF published on 01/29/2026 at 06:55, 5 months 9 days ago Piramal Pharma annonce une baisse de son chiffre d'affaires et de ses bénéfices pour le troisième trimestre et les neuf premiers mois de l'exercice 2026. Marge D'EBITDA Baisse Des Revenus Financement Biopharmaceutique Acquisition De Kenalog Extension Des Installations
PRESS RELEASE published on 01/29/2026 at 06:50, 5 months 9 days ago Piramal Pharma Limited Announces Results for Q3 and 9M FY26 Piramal Pharma Limited reports Q3 & 9M FY26 results with revenue impact, EBITDA efforts, and future growth prospects. Key highlights and financial performance discussed EBITDA Financial Performance Q3 Results Growth Prospects Piramal Pharma Limited
BRIEF published on 01/09/2026 at 22:00, 5 months 28 days ago Piramal Pharma Scores Higher on 2025 S&P Global Sustainability Assessment Pharmaceutical Industry Sustainability ESG Performance S&P Global CSA Piramal Pharma
Published on 07/07/2026 at 15:00, 2 hours 14 minutes ago Four Nines Gold Enhances Investor Communications as Hayden Hill Advances Toward Drilling Phase
Published on 07/07/2026 at 14:45, 2 hours 29 minutes ago Mako Mining Reports Proven and Probable Mineral Reserves of 598 Koz Au and 6.30 Moz Ag Grading 0.327 g/t Au and 3.45 g/t Ag in 56.8 M Tonnes at the Moss Mine in Arizona, Supporting a Post-Tax NPV 5% of US$254 Million and a 15-Year Mine Life at US$3,500/oz
Published on 07/07/2026 at 14:30, 2 hours 44 minutes ago Sekur Private Data Appoints Special Operations Communications Chief Master Sergeant (Ret.) Rafael Beltran to Its OpsTech Special Advisory Board
Published on 07/07/2026 at 14:00, 3 hours 14 minutes ago First Canadian Graphite Announces Significant New Discovery at Lac Guéret South
Published on 07/07/2026 at 14:00, 3 hours 14 minutes ago First Canadian Graphite annonce une nouvelle découverte majeure à Lac Guéret Sud
Published on 07/07/2026 at 17:05, 8 minutes ago CBME China 2026 Opens July 15-17: Where the Global Baby & Kids Industry Defines Its Next Chapter
Published on 07/07/2026 at 16:35, 38 minutes ago Asana Partners and Norges Bank Investment Management Launch Strategic Neighborhood Retail Venture
Published on 07/07/2026 at 16:50, 23 minutes ago Half-yearly report relative to the liquidity contract as of June 30, 2026
Published on 07/07/2026 at 16:50, 23 minutes ago Bilan semestriel du contrat de liquidité au 30 juin 2026
Published on 07/07/2026 at 16:40, 33 minutes ago Disclosure of Share Capital and Voting Rights as of June 30, 2026
Published on 07/07/2026 at 16:40, 33 minutes ago Déclaration du nombre d’actions et droits de vote au 30 juin 2026
Published on 07/07/2026 at 16:38, 36 minutes ago Disclosure of Share Capital and Voting Rights as of May 31, 2026
